Pharmaceutical News

RSS

Targeted polymersomes boost methotrexate efficacy for aggressive choriocarcinoma treatment

Researchers develop targeted polymersomes loaded with methotrexate for the treatment of gestational choriocarcinoma,

11 Feb 2025

Advances in the design and synthesis of isosteviol derivatives

Announcing a new publication for Acta Materia Medica journal. Isosteviol and its derivatives, diterpene compounds with a wide range of biological activities, play important antiviral, antibacterial, antioxidant, antitumor, analgesic, anti-inflammatory, antipyretic, antifungal, and anticardiovascular disease roles.

11 Feb 2025

Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).

10 Feb 2025

Neoantigen vaccine sparks powerful immune defense against kidney cancer

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to long-lasting T cell expansion and no disease recurrence after 40 months.

6 Feb 2025

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced positive topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy volunteers.

From SAb Biotherapeutics, Inc. 6 Feb 2025

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents.

6 Feb 2025

Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

Yokogawa Electric Corporation announces the release today of OpreX™ Quality Management System, a product in the OpreX Operational Risk Management family.

5 Feb 2025

GLP-1 drug exenatide shows no benefit for Parkinson's in new study

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

4 Feb 2025

Study finds global underuse of medications for cardiovascular disease prevention

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature mortality rates, according to study published today in JACC, the flagship journal of the American College of Cardiology.

4 Feb 2025

Study reveals mixed results for common stimulant in treating binge eating disorder

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers.

3 Feb 2025

Ancient drug could save NHS millions each year when treating older patients with heart conditions

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

31 Jan 2025

New FDA initiatives focus on medication safety for pregnant and nursing women

Women who are pregnant or breastfeeding often need to take prescription medications.

31 Jan 2025

Community pharmacists show higher assertiveness with multidisciplinary training

Community Pharmacists, as integral members of the healthcare system, play a crucial role in ensuring the safe and effective use of medicines.

31 Jan 2025

Emerging antibiotics at risk of resistance before clinical use

Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have made a concerning discovery about the future of antibiotics.

31 Jan 2025

Anxiety reduction with antidepressants confirmed, long-term effects uncertain

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

30 Jan 2025

GLP-1RA initiation linked to new thyroid cancer diagnoses

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor agonists.

28 Jan 2025

Rural clinics significantly boost buprenorphine prescribing with support program

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary care clinicians currently prescribe medication for OUD (MOUD).

27 Jan 2025

New approach uses peptides to enhance anti-tumor drug formulations

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

24 Jan 2025

Research develops framework to compare lab, AI, and simulation data

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

24 Jan 2025

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and efficacy. While ischemic stroke rates were slightly higher, they were not statistically significant, warranting further phase 3 trials for confirmation.

23 Jan 2025

Pharmaceutical News

Targeted polymersomes boost methotrexate efficacy for aggressive choriocarcinoma treatment

Advances in the design and synthesis of isosteviol derivatives

Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Neoantigen vaccine sparks powerful immune defense against kidney cancer

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

GLP-1 drug exenatide shows no benefit for Parkinson's in new study

Study finds global underuse of medications for cardiovascular disease prevention

Study reveals mixed results for common stimulant in treating binge eating disorder

Ancient drug could save NHS millions each year when treating older patients with heart conditions

New FDA initiatives focus on medication safety for pregnant and nursing women

Community pharmacists show higher assertiveness with multidisciplinary training

Emerging antibiotics at risk of resistance before clinical use

Anxiety reduction with antidepressants confirmed, long-term effects uncertain

GLP-1RA initiation linked to new thyroid cancer diagnoses

Rural clinics significantly boost buprenorphine prescribing with support program

New approach uses peptides to enhance anti-tumor drug formulations

Research develops framework to compare lab, AI, and simulation data

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News